Back to search

Development of a hammerhead ribozyme against BCL-2. II. Ribozyme treatment sensitizes hormone-resistant prostate cancer cells to apoptotic agents.

Thambi Dorai, E T Goluboff, Craig A. Olsson, Ralph Buttyan
PubMed

Data up to Jan 2025

Published1997
Citations45
References0
Fields
BiologyCancer researchMolecular biologyBiochemistry

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

Development of a hammerhead ribozyme against BCL-2. II. Ribozyme treatment sensitizes… (1997) – PubMed | Metascience Observatory Explorer